Isao Aoyama

1.0k total citations
18 papers, 817 citations indexed

About

Isao Aoyama is a scholar working on Nephrology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Isao Aoyama has authored 18 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 6 papers in Molecular Biology and 6 papers in Clinical Biochemistry. Recurrent topics in Isao Aoyama's work include Chronic Kidney Disease and Diabetes (9 papers), Dialysis and Renal Disease Management (6 papers) and Advanced Glycation End Products research (5 papers). Isao Aoyama is often cited by papers focused on Chronic Kidney Disease and Diabetes (9 papers), Dialysis and Renal Disease Management (6 papers) and Advanced Glycation End Products research (5 papers). Isao Aoyama collaborates with scholars based in Japan, Switzerland and United States. Isao Aoyama's co-authors include Toshimitsu Niwa, Takashi Miyazaki, Kaoru Shimokata, Fumio Takayama, Atsushi Enomoto, Toshimitsu Niwa, Hisao Seo, Michihito Ise, Sakurako Nakamura and Takashi Sekine and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

Isao Aoyama

17 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isao Aoyama Japan 14 465 147 146 122 121 18 817
Michihito Ise Japan 9 478 1.0× 130 0.9× 114 0.8× 117 1.0× 100 0.8× 14 768
Sakurako Nakamura Japan 12 330 0.7× 131 0.9× 254 1.7× 87 0.7× 137 1.1× 15 683
Saori Tsukushi Japan 11 286 0.6× 91 0.6× 131 0.9× 101 0.8× 89 0.7× 14 523
Dhruv K. Singh United Kingdom 11 287 0.6× 202 1.4× 115 0.8× 119 1.0× 158 1.3× 19 798
Toshimitsu Niwa Japan 11 300 0.6× 197 1.3× 200 1.4× 124 1.0× 86 0.7× 12 670
R Dzúrik Slovakia 15 265 0.6× 157 1.1× 193 1.3× 147 1.2× 157 1.3× 113 828
Hideyuki Horike Japan 8 183 0.4× 148 1.0× 89 0.6× 134 1.1× 78 0.6× 24 679
Gregory Proctor United States 5 240 0.5× 279 1.9× 85 0.6× 141 1.2× 187 1.5× 5 849
Dilinaer Bolati Japan 9 384 0.8× 284 1.9× 61 0.4× 134 1.1× 59 0.5× 10 760
Ayinuer Adijiang Japan 14 430 0.9× 415 2.8× 92 0.6× 179 1.5× 127 1.0× 18 1.1k

Countries citing papers authored by Isao Aoyama

Since Specialization
Citations

This map shows the geographic impact of Isao Aoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Aoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Aoyama more than expected).

Fields of papers citing papers by Isao Aoyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Aoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Aoyama. The network helps show where Isao Aoyama may publish in the future.

Co-authorship network of co-authors of Isao Aoyama

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Aoyama. A scholar is included among the top collaborators of Isao Aoyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Aoyama. Isao Aoyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Inaguma, Daijo, Isao Aoyama, Shinichiro Inaba, et al.. (2018). Serum phosphate level at initiation of dialysis is associated with all-cause mortality: a multicenter prospective cohort study. Renal Failure. 40(1). 475–482. 7 indexed citations
2.
Aoyama, Isao, et al.. (2009). High Ambient Glucose Augments Angiotensin II-Induced Proinflammatory Gene mRNA Expression in Human Mesangial Cells: Effects of Valsartan and Simvastatin. American Journal of Nephrology. 30(2). 99–111. 16 indexed citations
3.
Hori, Mayuko, et al.. (2009). [Case of tuberculosis-associated hemophagocytic syndrome in a hemodialysis patient under steroid therapy].. PubMed. 51(8). 1091–5. 2 indexed citations
4.
Aoyama, Isao, Atsushi Enomoto, & Toshimitsu Niwa. (2003). Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis. American Journal of Kidney Diseases. 41(3). S8–S14. 31 indexed citations
5.
Nakamura, Sakurako, Tetsuya Tachikawa, Isao Aoyama, et al.. (2003). An inhibitor of advanced glycation end product formation reducesN-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats. American Journal of Kidney Diseases. 41(3). S68–S71. 16 indexed citations
6.
Enomoto, Atsushi, Michio Takeda, Akihiro Tojo, et al.. (2002). Role of Organic Anion Transporters in the Tubular Transport of Indoxyl Sulfate and the Induction of its Nephrotoxicity. Journal of the American Society of Nephrology. 13(7). 1711–1720. 261 indexed citations
7.
Aoyama, Isao, Kaoru Shimokata, & Toshimitsu Niwa. (2002). An Oral Adsorbent Downregulates Renal Expression of Genes That Promote Interstitial Inflammation and Fibrosis in Diabetic Rats. ˜The œNephron journals/Nephron journals. 92(3). 635–651. 49 indexed citations
8.
Aoyama, Isao, Kaoru Shimokata, & Toshimitsu Niwa. (2002). Combination Therapy with Benazepril and Oral Adsorbent Ameliorates Progressive Renal Fibrosis in Uremic Rats. ˜The œNephron journals/Nephron journals. 90(3). 297–312. 32 indexed citations
9.
Aoyama, Isao & Toshimitsu Niwa. (2001). An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats. American Journal of Kidney Diseases. 37(1). S7–S12. 49 indexed citations
10.
Aoyama, Isao, Kaoru Shimokata, & Toshimitsu Niwa. (2000). Oral Adsorbent AST-120 Ameliorates Interstitial Fibrosis and Transforming Growth Factor-β<sub>1</sub> Expression in Spontaneously Diabetic (OLETF) Rats. American Journal of Nephrology. 20(3). 232–241. 38 indexed citations
11.
Miyazaki, Takashi, Isao Aoyama, Michihito Ise, Hisao Seo, & Toshimitsu Niwa. (2000). An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF‐β1 in uraemic rat kidneys. Nephrology Dialysis Transplantation. 15(11). 1773–1781. 141 indexed citations
12.
Aoyama, Isao, Takashi Miyazaki, & Toshimitsu Niwa. (1999). Preventive Effects of an Oral Sorbent on Nephropathy in Rats. PubMed. 25(4-6). 365–372. 27 indexed citations
13.
Niwa, Toshimitsu, Isao Aoyama, Fumio Takayama, et al.. (1999). Uremic Toxicity: Urinary Indoxyl Sulfate is a Clinical Factor that Affects the Progression of Renal Failure. PubMed. 25(1-2). 118–122. 39 indexed citations
14.
Aoyama, Isao, Takashi Miyazaki, Fumio Takayama, et al.. (1999). Oral adsorbent ameliorates renal TGF-β1 expression in hypercholesterolemic rats. Kidney International. 56. S193–S197. 23 indexed citations
15.
Tsukushi, Saori, Tomoyuki Katsuzaki, Isao Aoyama, et al.. (1999). Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: Role of the polyol pathway. Kidney International. 55(5). 1970–1976. 60 indexed citations
16.
Takayama, Fumio, Takashi Miyazaki, Isao Aoyama, et al.. (1998). Involvement of interleukin-8 in dialysis-related arthritis. Kidney International. 53(4). 1007–1013. 12 indexed citations
17.
Takayama, Fumio, Takashi Miyazaki, Isao Aoyama, et al.. (1998). Involvement of interleukin-8 in dialysis-related arthritis. Kidney International. 53(4). 1007–1013. 1 indexed citations
18.
Aoyama, Isao, et al.. (1967). Evaluation of phenyl acetate esterase activity as an index of liver damage. Clinica Chimica Acta. 18(1). 21–32. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026